Skip to main content
NCBI home page
Occupational and Environmental Medicine logoLink to Occupational and Environmental Medicine
. 1997 Oct;54(10):756–761. doi: 10.1136/oem.54.10.756

Outcome determinants for isocyanate induced occupational asthma among compensation claimants.

S M Tarlo 1, D Banks 1, G Liss 1, I Broder 1
PMCID: PMC1128932  PMID: 9404325

Abstract

OBJECTIVES: To compare the outcome of occupational asthma (OA) induced by isocyanates in Ontario (where a surveillance programme for exposed workers has been in place for over 15 years), with the outcome of OA induced by other work agents. METHODS: Compensated OA claims during the period 1984-88 in Ontario were retrospectively reviewed in a standardised way. RESULTS: 136/235 compensated claims were attributed to isocyanates. Compared with other causes of OA, those attributed to isocyanates had a shorter latent period before onset (5.9 v 7.9 years, P < 0.05), shorter duration of symptoms before diagnosis (2.0 v 3.0 years, P < 0.05), and less associated atopy (43% v 58%, P < 0.05). Outcome at a mean of 1.9 years after initial assessment was significantly better in those with OA induced by isocyanates; 73% cleared or improved v 56% with other causes of OA (P < 0.05). Ten subjects with OA induced by isocyanates stayed at the same work; none cleared and four had worsened at follow up. A better outcome in OA induced by isocyanates was associated with early diagnosis (P < 0.05), and early removal from isocyanates after the onset of asthma. CONCLUSIONS: The outcome in the group with OA induced by isocyanates is similar to previous follow up studies. However, it is better than the outcome in our comparison group with OA due to other causes, perhaps because of earlier diagnosis in the group with OA induced by isocyanates. This may be attributable to the medical surveillance of workers exposed to isocyanates in Ontario, either directly from the surveillance assessments, or indirectly by increasing awareness of the condition.

Full text

PDF
756

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein D. I., Korbee L., Stauder T., Bernstein J. A., Scinto J., Herd Z. L., Bernstein I. L. The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol. 1993 Sep;92(3):387–396. doi: 10.1016/0091-6749(93)90117-x. [DOI] [PubMed] [Google Scholar]
  2. Chan-Yeung M., MacLean L., Paggiaro P. L. Follow-up study of 232 patients with occupational asthma caused by western red cedar (Thuja plicata). J Allergy Clin Immunol. 1987 May;79(5):792–796. doi: 10.1016/0091-6749(87)90212-0. [DOI] [PubMed] [Google Scholar]
  3. Cote J., Kennedy S., Chan-Yeung M. Outcome of patients with cedar asthma with continuous exposure. Am Rev Respir Dis. 1990 Feb;141(2):373–376. doi: 10.1164/ajrccm/141.2.373. [DOI] [PubMed] [Google Scholar]
  4. Lozewicz S., Assoufi B. K., Hawkins R., Taylor A. J. Outcome of asthma induced by isocyanates. Br J Dis Chest. 1987 Jan;81(1):14–22. doi: 10.1016/0007-0971(87)90103-3. [DOI] [PubMed] [Google Scholar]
  5. Malo J. L., Ghezzo H., D'Aquino C., L'Archevêque J., Cartier A., Chan-Yeung M. Natural history of occupational asthma: relevance of type of agent and other factors in the rate of development of symptoms in affected subjects. J Allergy Clin Immunol. 1992 Dec;90(6 Pt 1):937–944. doi: 10.1016/0091-6749(92)90466-f. [DOI] [PubMed] [Google Scholar]
  6. Mapp C. E., Corona P. C., De Marzo N., Fabbri L. Persistent asthma due to isocyanates. A follow-up study of subjects with occupational asthma due to toluene diisocyanate (TDI). Am Rev Respir Dis. 1988 Jun;137(6):1326–1329. doi: 10.1164/ajrccm/137.6.1326. [DOI] [PubMed] [Google Scholar]
  7. Meredith S. K., Taylor V. M., McDonald J. C. Occupational respiratory disease in the United Kingdom 1989: a report to the British Thoracic Society and the Society of Occupational Medicine by the SWORD project group. Br J Ind Med. 1991 May;48(5):292–298. doi: 10.1136/oem.48.5.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Paggiaro P. L., Loi A. M., Rossi O., Ferrante B., Pardi F., Roselli M. G., Baschieri L. Follow-up study of patients with respiratory disease due to toluene diisocyanate (TDI). Clin Allergy. 1984 Sep;14(5):463–469. doi: 10.1111/j.1365-2222.1984.tb02230.x. [DOI] [PubMed] [Google Scholar]
  9. Paggiaro P. L., Vagaggini B., Dente F. L., Bacci E., Bancalari L., Carrara M., Di Franco A., Giannini D., Giuntini C. Bronchial hyperresponsiveness and toluene diisocyanate. Long-term change in sensitized asthmatic subjects. Chest. 1993 Apr;103(4):1123–1128. doi: 10.1378/chest.103.4.1123. [DOI] [PubMed] [Google Scholar]
  10. Pisati G., Baruffini A., Zedda S. Toluene diisocyanate induced asthma: outcome according to persistence or cessation of exposure. Br J Ind Med. 1993 Jan;50(1):60–64. doi: 10.1136/oem.50.1.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rosenberg N., Garnier R., Rousselin X., Mertz R., Gervais P. Clinical and socio-professional fate of isocyanate-induced asthma. Clin Allergy. 1987 Jan;17(1):55–61. doi: 10.1111/j.1365-2222.1987.tb02319.x. [DOI] [PubMed] [Google Scholar]
  12. Tarlo S. M., Broder I. Outcome of assessments for occupational asthma. Chest. 1991 Aug;100(2):329–335. doi: 10.1378/chest.100.2.329. [DOI] [PubMed] [Google Scholar]
  13. Tarlo S. M., Liss G., Corey P., Broder I. A workers' compensation claim population for occupational asthma. Comparison of subgroups. Chest. 1995 Mar;107(3):634–641. doi: 10.1378/chest.107.3.634. [DOI] [PubMed] [Google Scholar]

Articles from Occupational and Environmental Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES